Insulet reported $689M in Trade Debtors for its fiscal quarter ending in September of 2026.





Trade Debtors Change Date
Abbott USD 11.22B 655M Mar/2026
Align Technology USD 1.16B 15.46M Sep/2026
AtriCure USD 76.13M 3.85M Sep/2026
Baxter International USD 1.86B 158M Jun/2026
Becton, Dickinson and Co. USD 2.77B 407M Sep/2026
Boston Scientific USD 3.05B 22M Jun/2026
Cardinal Health USD 14.54B 727M Sep/2026
Cooper Companies USD 788.9M 20.3M Jun/2026
Dexcom USD 1.27B 175.4M Jun/2026
Edwards Lifesciences USD 937.8M 17.9M Sep/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Globus Medical USD 723.95M 15.33M Sep/2026
ICU Medical USD 206.26M 22.73M Sep/2026
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 689M 100.3M Sep/2026
Integra LifeSciences USD 248.99M 18.19M Sep/2026
J&J USD 19.05B 3.49B Jun/2026
Medtronic USD 6.36B 286M Jun/2026
Merit Medical Systems USD 250.9M 23.9M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Solventum Corp USD 1.39B 302M Sep/2026
Stryker USD 3.74B 172M Jun/2026
Tandem Diabetes Care USD 180.02M 17.96M Sep/2026
Teleflex USD 379.64M 15.03M Sep/2026
West Pharmaceutical Services USD 748.2M 36.2M Sep/2026
Zimmer Biomet Holdings USD 1.82B 46.5M Sep/2026